{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:25:03Z","timestamp":1763457903471,"version":"3.41.2"},"reference-count":36,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Vertex Pharmaceuticals and Pfizer"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Patients with immunodeficiency or cystic fibrosis frequently suffer from respiratory fungal infections. In particular, biofilm-associated fungi cause refractory infection manifestations, linked to increased resistance to anti-infective agents. One emerging filamentous fungus is Lomentospora prolificans. Here, the biofilm-formation capabilities of L. prolificans isolates were investigated and the susceptibility of biofilms to various antifungal agents was analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Biofilm formation of L. prolificans (n\u2009=\u200911) was estimated by crystal violet stain and antibiofilm activity was additionally determined via detection of metabolically active biofilm using an XTT assay. Amphotericin B, micafungin, voriconazole and olorofim were compared with regard to their antibiofilm effects when added prior to adhesion, after adhesion and on mature and preformed fungal biofilms. Imaging via confocal laser scanning microscopy was carried out to demonstrate the effect of drug treatment on the fungal biofilm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Antibiofilm activities of the tested antifungal agents were shown to be most effective on adherent cells whilst mature biofilm was the most resistant. The most promising antibiofilm effects were detected with voriconazole and olorofim. Olorofim showed an average minimum biofilm eradication concentration (MBEC) of 0.06\u2009mg\/L, when added prior to and after adhesion. The MBECs of voriconazole were \u22644\u2009mg\/L. On mature biofilm the MBECs of olorofim and voriconazole were higher than the previously determined MICs against planktonic cultures. In contrast, amphotericin B and especially micafungin did not exhibit sufficient antibiofilm activity against L. prolificans.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>To our knowledge, this is the first study demonstrating the antibiofilm potential of olorofim against the human pathogenic fungus L. prolificans.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa157","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T11:10:00Z","timestamp":1585739400000},"source":"Crossref","is-referenced-by-count":14,"title":["Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-275X","authenticated-orcid":false,"given":"Lisa","family":"Kirchhoff","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Dittmer","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kathrin","family":"Weisner","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Buer","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter-Michael","family":"Rath","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Steinmann","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"},{"name":"Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Klinikum N\u00fcrnberg, Paracelsus Medical University, Nuremberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"2020050917180910800_dkaa157-B1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"2020050917180910800_dkaa157-B2","doi-asserted-by":"crossref","first-page":"76.","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: an emerging battleground in microbial communities","volume":"8","author":"Sharma","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"2020050917180910800_dkaa157-B3","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/clinids\/22.Supplement_2.S112","article-title":"The new fungal opportunists are coming","volume":"22","author":"Perfect","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020050917180910800_dkaa157-B4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s100960050011","article-title":"Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis","volume":"19","author":"Cimon","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020050917180910800_dkaa157-B5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/jac\/dkx065","article-title":"Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans","volume":"72","author":"Wiederhold","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020050917180910800_dkaa157-B6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijantimicag.2017.06.009","article-title":"Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?","volume":"51","author":"Pellon","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2020050917180910800_dkaa157-B7","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.05910-11","article-title":"Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species","volume":"56","author":"Lackner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050917180910800_dkaa157-B8","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1128\/AAC.03211-14","article-title":"Susceptibility and diversity in the therapy-refractory genus Scedosporium","volume":"58","author":"Lackner","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050917180910800_dkaa157-B9","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050917180910800_dkaa157-B10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-002-0877-z","article-title":"Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine","volume":"22","author":"Howden","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020050917180910800_dkaa157-B11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.01.012","article-title":"Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope\u00ae registry 2008\u20132019","author":"Jenks","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2020050917180910800_dkaa157-B12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/43.1.149","article-title":"Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum","volume":"43","author":"Cuenca-Estrella","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"2020050917180910800_dkaa157-B13","doi-asserted-by":"crossref","first-page":"e00231","DOI":"10.1128\/AAC.00231-18","article-title":"Effect of the novel antifungal drug F901318 (olorofim) on growth and viability of Aspergillus fumigatus","volume":"62","author":"du Pr\u00e9","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050917180910800_dkaa157-B14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jgg.2015.04.004","article-title":"Pyrimidine metabolism: dynamic and versatile pathways in pathogens and cellular development","volume":"42","author":"Garavito","year":"2015","journal-title":"J Genet Genomics"},{"key":"2020050917180910800_dkaa157-B15","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/jac\/dkx177","article-title":"In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates","volume":"72","author":"Buil","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020050917180910800_dkaa157-B16","doi-asserted-by":"crossref","first-page":"42886.","DOI":"10.1038\/srep42886","article-title":"Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents","volume":"7","author":"Kirchhoff","year":"2017","journal-title":"Sci Rep"},{"year":"2015","author":"Arendrup","key":"2020050917180910800_dkaa157-B17"},{"key":"2020050917180910800_dkaa157-B18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10096-015-2374-1","article-title":"Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification","volume":"34","author":"Araujo","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020050917180910800_dkaa157-B19","doi-asserted-by":"crossref","first-page":"490.e1","DOI":"10.1016\/j.cmi.2014.12.021","article-title":"Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality","volume":"21","author":"Slavin","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2020050917180910800_dkaa157-B20","first-page":"1050","article-title":"In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi","volume":"56","author":"Biswas","year":"2018","journal-title":"Med Mycol"},{"key":"2020050917180910800_dkaa157-B21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/08927014.2018.1503652","article-title":"Surface properties, adhesion and biofilm formation on different surfaces by Scedosporium spp. and Lomentospora prolificans","volume":"34","author":"Mello","year":"2018","journal-title":"Biofouling"},{"key":"2020050917180910800_dkaa157-B22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.genet.35.102401.090913","article-title":"Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing","volume":"35","author":"Fuqua","year":"2001","journal-title":"Annu Rev Genet"},{"key":"2020050917180910800_dkaa157-B23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.cellbio.21.012704.131001","article-title":"Quorum sensing: cell-to-cell communication in bacteria","volume":"21","author":"Waters","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2020050917180910800_dkaa157-B24","doi-asserted-by":"crossref","first-page":"1568.","DOI":"10.3389\/fmicb.2017.01568","article-title":"Biofilm formation by Pseudallescheria\/Scedosporium species: a comparative study","volume":"8","author":"Rollin-Pinheiro","year":"2017","journal-title":"Front Microbiol"},{"key":"2020050917180910800_dkaa157-B25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jobm.201900550","article-title":"Developmental stages of biofilm and characterization of extracellular matrix of manglicolous fungus Aspergillus niger BSC-1","volume":"60","author":"Chatterjee","year":"2020","journal-title":"J Basic Microbiol"},{"key":"2020050917180910800_dkaa157-B26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/23744235.2017.1384956","article-title":"The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data","volume":"50","author":"Tascini","year":"2018","journal-title":"Infect Dis"},{"key":"2020050917180910800_dkaa157-B27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1099\/jmm.0.47247-0","article-title":"Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus","volume":"56","author":"Mowat","year":"2007","journal-title":"J Med Microbiol"},{"key":"2020050917180910800_dkaa157-B28","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/AAC.00234-08","article-title":"Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells","volume":"52","author":"Seidler","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050917180910800_dkaa157-B29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.mib.2006.10.003","article-title":"How to build a biofilm: a fungal perspective","volume":"9","author":"Blankenship","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"2020050917180910800_dkaa157-B30","doi-asserted-by":"crossref","first-page":"187.","DOI":"10.1007\/s11274-016-2146-9","article-title":"Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid","volume":"32","author":"Kvasni\u010dkov\u00e1","year":"2016","journal-title":"World J Microbiol Biotechnol"},{"key":"2020050917180910800_dkaa157-B31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/jac\/dkn402","article-title":"Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms","volume":"62","author":"Mowat","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2020050917180910800_dkaa157-B32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/00365540110080340","article-title":"Post-antifungal effect and effects of sub-MIC concentrations on previously treated Candida spp.: influence of exposure time and concentration","volume":"34","author":"Garc\u00eda","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"2020050917180910800_dkaa157-B33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jac\/dkh459","article-title":"Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration","volume":"54","author":"Chryssanthou","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2020050917180910800_dkaa157-B34","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/AAC.41.6.1392","article-title":"Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans","volume":"41","author":"Klepser","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2020050917180910800_dkaa157-B35","doi-asserted-by":"crossref","first-page":"e31252.","DOI":"10.1371\/journal.pone.0031252","article-title":"The pyrimidine nucleotide biosynthetic pathway modulates production of biofilm determinants in Escherichia coli","volume":"7","author":"Garavaglia","year":"2012","journal-title":"PLoS One"},{"key":"2020050917180910800_dkaa157-B36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1462-2920.2005.00775.x","article-title":"Characterization of starvation-induced dispersion in Pseudomonas putida biofilms","volume":"7","author":"Gjermansen","year":"2005","journal-title":"Environ Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkaa157\/33199303\/dkaa157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkaa157\/33199303\/dkaa157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T21:18:28Z","timestamp":1589059108000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/advance-article\/doi\/10.1093\/jac\/dkaa157\/5835360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa157","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published":{"date-parts":[[2020,5,9]]},"article-number":"dkaa157"}}